Concourse Financial Group Securities’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10372 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10644 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10532 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10174 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9945 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9713 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9468 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9248 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8896 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8904 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8710 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8549 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8352 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8090 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7684 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7333 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7028 |
|